Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 20 years old
- People who are willing to sign an informed consent form (a document agreeing to take part in the study)
- People who have been diagnosed with their condition themselves (confirm with trial site)
- People who hold a Taiwanese ID
- People who have atherosclerotic vascular disease (a condition where the arteries become narrowed or hardened due to plaque buildup) and also have at least one of the following risk factors: diabetes, high cholesterol or currently taking cholesterol-lowering medication, high blood pressure, smoking, older age (men over 45 or women over 55), a family history of early heart disease, or obesity
Who may not be able to join:
- People who are not willing to sign the informed consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chau C Wu, M.D., Ph.D., National Taiwan University Hospital
Phone: 886-2-23123456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite cardiovascular outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.